Please provide your email address to receive an email when new articles are posted on . Bone marrow aspirate concentrate injections may not provide benefit as an adjuvant for arthroscopic partial ...

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec, an innovative medical device company specializing in orthopedic and spine technology, is thrilled to announce that it has received 510(k) clearance from ...

The U.S. FDA granted Scopio Labs Ltd. de novo clearance for its artificial intelligence (AI)-powered software which analyzes bone marrow. Scopio’s Full-Field Bone Marrow Aspirate (FF-BMA) system aims ...

Israel-based Scopio Labs announced the FDA granted De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) software that provides AI-enabled decision support tools for bone marrow analysis.

A novel 3D-printed scaffold for patient-specific partial breast reconstruction: A prospective, single-arm clinical trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...

Medically reviewed by Gagandeep Brar, MD Key Takeaways Bone marrow fills the cavities in your bones and produces blood ...

Stem cell treatment targeting the bone beneath the knee reduced pain and improved movement more effectively than joint injections in osteoarthritis patients.

Researchers estimate that about 20% of patients who undergo anterior cruciate ligament (ACL) reconstruction will develop posttraumatic osteoarthritis (OA) within 10 years after surgery. That ...

Medically reviewed by Doru Paul, MD Key Takeaways Myelosuppression is when bone marrow can't make enough blood cells. Treatment depends on the cause.Chemotherapy can cause myelosuppression by hurting ...

SurGenTec, an innovative medical device company specializing in orthopedic and spine technology, is thrilled to announce that it has received 510(k) clearance from the U.S. Food and Drug ...